Sanofi’s vaccines business leaned on strong performances from pediatric, flu and travel shots on the way to 13.2% growth in Q1.
WHO plans real-world pilot studies of GlaxoSmithKline’s malaria jab Mosquirix in three African countries.
Three biosimilars for rheumatoid arthritis (RA) were approved by the FDA last year, but the regulatory pathway in the US is still considered a new frontier,…
Vaccination rates among kindergarteners reached a record high in California after a tougher vaccine law went into effect.
Themis is the most recent company to usher a Zika vaccine to the clinic.
Sanofi Pasteur's dengue vaccine Dengvaxia will have to undergo phase 4 testing in Malaysia.
GlaxoSmithKline’s U.S. vaccine R&D head Ripley Ballou says emerging disease vaccine research needs a shakeup—and here's how.
Argentina's Sinergium Biotech, which is in a consortium to develop a Zika virus vaccine, intends to build a new plant that will use cell biology that can…
Takeda has finished enrolling 20,100 children for a massive phase 3 dengue vaccine study.
After successfully shepherding a Zika vaccine candidate into the clinic before any other developer, Inovio Pharmaceuticals is amping up its efforts in HIV.
The NIH's Zika vaccine will move into phase 2 testing, officials said Friday. Despite the president's threats of spending cuts, this project is fully…